Day One: June 14, 2013
7:00-8:00am
Registration & Exhibits
8:00-9:45am
Clinical Track: Detecting and Treating COPD Co-morbidities: A path to improving overall health?
Session Chair: Mark Dransfield, MD
COPD doesn’t occur in isolation and patients are documented to be at risk for several co-morbid conditions. The session will include short presentations from experts with discussion on how incorporating strategies for each condition into COPD treatment plans may improve outcomes.
1. An Overview (Victor Pinto-Plata, MD) 2. Cardiac Co-morbidities of COPD (Mark Dransfield, MD) 3. Bone Mineral Density Loss and
Muscle Dysfunction in COPD (Jessica Bon, MD) 4. Approaching Co-morbid Anxiety and Depression in COPD (Barry Make, MD) 5. COPD and
Lung Cancer (Betty Tran, MD)
Care Delivery Track: The Changing Face of Care Delivery-How Policy Decisions Drive Improvements in Care
Session Chair: Peter Salgo, MD
Clinicians and scientists do not often participate in the design and execution of quality improvement policy. CMS, private payers, the business community and a quality improvement organization will provide perspectives on implications for the delivery of COPD care from the move towards quality in ACA. The challenge panel will present questions and the facilitator will moderate the discussion to bridge the gap between policy level decisions and real world practicalities of achieving better outcomes for COPD patients.
1. Why Policy Changes and Quality Improvement Matter to COPD (Richard Mularski, MD) 2. The Employer’s Role in Quality Improvement (Larry Boress, MPA) 3. SPPCMH-An example of policy driving change (Rhea Powell, MD) 4. CMS Competitive Bidding Program and Insurance Marketplaces (Tangita Daramola) 5. Challenge Panel: Thomas Kallstrom, RRT, Richard Casaburi, MD, Jean Rommes, PhD, Barbara Yawn, MD, Patricia Jellen, RN)
Research Track: New Advances in Understanding the Physiology of COPD
Session Chair: Robert Wise, MD
Recent advances in understanding altered physiology in COPD will be reviewed, including the interactions
between dynamic hyperinflation, chest wall and dyspnea, the role of small airways, the role of skeletal muscle dysfunction in the
context of clinical outcomes, and the interaction between COPD and sleep.
1. Chest Wall and Lung Mechanics in the Patient with COPD (Charles Irvin, PhD) 2. Peripheral Muscle Function in COPD (Francois Maltais, PhD)
3. Small Airway Structure and Function in COPD (James Hogg, MD, PhD) 4. Sleep Pathology in COPD (Cynthia Brown, MD)
9:45-10:00am
Refreshment Break & Exhibits
10:00am-12:00pm
Keynote Plenary Session: The State of COPD in 2013
The keynote plenary provides an overview of the top clinical, care delivery, research and policy developments and challenges in COPD from the perspective of key experts, decision makers and a patient. This will provide participants with a framework for enhancing the usefulness of their conference experience. Senator Richard Durbin of Illinois, Co-Chair of the COPD Congressional Caucus has been invited to present the keynote.
1. Perspectives: Research Community-Antonello Punturieri, MD, PhD , Payer -TBD, Patient Centered Outcomes Research (David Hickman, MD, MPH), International-Sonia Buist, MD, Patient (John Walsh), Clinician-Primary Care (TBD), Clinician-Pulmonologist (Ravi Kalhan, MD) 2. Keynote Presentation: A View From the Hill (Senator Richard Durbin-invited) 3. Key Considerations for Maximizing your COPD8usa Experience (Barbara Yawn, MD)
12:00-1:15pm
Lunch & Exhibits
1:15-3:00pm
Clinical Track-Management of Advanced COPD
Session Chair: Ravi Kalhan, MD
A facilitated roundtable on the care of people with advanced disease, the session will be organized around questions posed by participants in advance of the session on challenges they face when caring for advanced disease. There will be open discussion among panel members who have complementary expertise.
1. Panel Perspectives: Pulmonologist (Barry Make, MD), Primary Care (Barbara Yawn, MD), Pulmonary Rehabilitation (Nancy Quesada, MD), Respiratory Nurse (Patricia Jellen, RN), Respiratory Therapy Perspective (Ellen Becker, PhD, RRT-NPS, RPFT, AE-C, FAARC), Palliative Care (Eytan Szmuilowicz, MD)
Care Delivery Track-How Patient Centered Outcomes Research Can Drive Evidence Based Policy & Lead to Better Clinical Outcomes
Session Chair: Jerry Krishnan, MD, PhD
An expert panel will review their activities in patient centered outcomes research (PCOR) and the top opportunities and challenges in PCOR today. The panel discussions will answer questions including; how do we know what the right questions to study are, what policies and infrastructure must be in place now to ensure the success of PCOR, how do we ensure PCOR will be used to build evidence for positive policy changes and how do we articulate the value of continued investment in PCOR? The concluding discussion willl identify the role of the COPD stakeholders in PCOR engagement.
1. Panel Perspectives: PCORI-(David Hickman, MD, MPH), Pharmaceutical Industry (Richard Sanford, PhD), CONCERT-(Richard Mularski, MD, MSHS, MCR), Patient Advocacy Organization (John Walsh) 2. Facilitated Discussion: Challenges and Opportunities (Jerry Krishnan, MD, PhD) 3. Discussion: The Role of the Clinical and Patient Community (Miriam O’Day)
Research Track: The Role of Neutrophils
Session Chair: Robert Stockley, MD
Review of recent advances in the understanding in neutrophil activation including how neutrophils lead to tissue damage. Emerging concepts of NET formation in clearing bacteria will be presented. The session will emphasize changing concepts around how to gauge neutrophilic inflammation in the lung and how a biomarker that serves as a measure of neutrophilic inflammation could be designed.
1. Animal Models: Neutrophils and their proteinases and Human Models: Neutrophils and tissue damage (Robert Stockley, MD) 3. Neutrophil Migration Defects and NETs in Tissue Damage (Elizabeth Sapey, PhD, MBBS, BSC) 4. Neutrophil Transit Times (Edwin Chilvers, MD)
3:00-3:15pm
Refreshment Break & Exhibits
3:15-5:00pm
The Alpha-1 Foundation Memorial Plenary Session: Nature versus Nurture in COPD
Recent investments in understanding the genetic and environmental factors that are important in the COPD development and progression have produced unprecedented data. The session will review current and completed studies including; COPDGene, NETT, ECLIPSE, TORCH, and UPLIFT. The discussion will focus on ways the findings from these studies can improve outcomes.
1. Nature: How the COPDGene Study will Transform the Way we Think About COPD (Edwin Silverman, MD, PhD) 2. Nurture: Early Life Exposures (Sonia Buist, MD) 3. Nurture: Later Life Exposures (David Mannino, MD) 4. Panel Discussion: Putting the Data to Work (Peter Salgo, MD)
5:15-6:15pm
Networking Hours
Take advantage of the unparalleled access to international COPD healthcare provider and research experts during the informal networking hours. The Young Clinician and Researcher Networking Hour will feature premier COPD expert, Bartolome Celli and two rising COPD stars who will field questions from those age 45 and under. The Pulmonary Rehabilitation Room will be the destination of choice for all those involved or interested in best practices for running a successful rehab program in these challenging times. Share and learn from peer experts and take advantage of the chance to question national rehab and exercise expert, Dr. Richard Casaburi.
6:30-8:00pm
Alpha-1 Memorial Reception and Poster Presentation: Is There a Roadmap to a Cure?
Celebrate the 50th Anniversary of the discovery of Alpha-1, view select abstract poster presentations and hear from Alpha-1 expert, Dr. Robert Sandhaus as he illustrates how the discovery of Alpha-1 50 years ago has brought the field closer to a cure for COPD. Patient advocate Grace Anne Dorney Koppel will conclude with her definition of a cure and a challenge to the whole community to answer her call to action.
Day Two: June 15, 2013
7:00-8:00am
Breakfast & Exhibits
8:00-9:30am
Plenary Session: 2013 COPD Guidelines-Where Are We Headed?
Session Chair: Frank Sciurba, MD
The 2011 update of the GOLD COPD Guidelines resulted in a shift of classification; incorporating components of lung function impairment, symptomatology and exacerbation history. The COPD Foundation has now launched its Guide to COPD Diagnosis and Therapy. These tools will be reviewed along with a discussion on how best to incorporate them into primary care.
1. Standards, Statements, Guidelines, Guides and Guidance (Stephen Rennard, MD) 2. A 2011 GOLD Guideline Update (Fernando Martinez, MD) 3. The COPD Foundation Guide to Diagnosis and Therapy: Do more domains provide better guidance? (Byron Thomashow, MD) 4. How to go from Guidelines to Practice: Do they actually work? (Mark Dransfield, MD) 5. Where do we go from Here? (Bartolome Celli, MD)
9:30-10:00am
Refreshment Break & Exhibits
10:00-12:00pm
Clinical Track: Opportunities to Advance the Care of COPD Exacerbations
Session Chair: Jerry Krishnan, MD, PhD
The session will focus on implementing new knowledge regarding COPD exacerbations into day-to-day clinical practice. A concluding discussion on what is known about preventing another hospitalization will focus on engaging audience insights into the challenges they face when a patient has been hospitalized.
1. Identifying Exacerbation Risk: What is the Best Approach? (Sharon Rosenberg, MD) 2. How do Patients Report they are Having an Exacerbation? (Susan Yount, PhD) 3. Is it Heart Failure or a COPD Exacerbation? (Patrick Godwin, MD) 4. Treating Exacerbations-Prednisone, antibiotics, or both? (Sanjay Sethi, MD) 5. Preventing another hospitalization (Jerry Krishnan, MD, PhD)
Care Delivery Track: The Team Approach-The Roles of the Healthcare Provider Team in Changing Delivery Environments
Session Chair: Peter Salgo, MD
Team based, patient-centered care is a necessity. The session addresses the situational differences faced by clinical teams in different delivery environments; academic centers, private practice, community hospitals, and newer models such as accountable care organizations and patient centered medical homes. Each roundtable will be lead by faculty practicing in one of the delivery models. Questions will be at each table for discussion, followed by facilitated discussion to identify barriers to team-based, patient-centered care.
1. Introduction & Overview of Key Questions (Peter Salgo, MD) 2. Roundtable Discussions: Table Leaders (Barbara Yawn, MD, Keith Robinson, MD, Pioneer ACO TBD, Byron Thomashow, MD, Cindy Gronkiewicz, RN, MS, APRN, AE-C, Tom Kallstrom, RRT) 3. Presentation of Roundtable Discussion Summaries 4. Facilitated Discussion (Peter Salgo, MD)
Research Track: Outstanding Research from COPD8USA Abstract Submissions
Session Chairs: Stephen Rennard, MD & Gerard Turino, MD
Junior investigators often lack a platform for presenting early career research and receiving feedback from more experienced investigators in their field. A call for original research will accompany the abstract submission process. Session chairs will review all original research selected and choose 4 early career investigators to present oral summaries during this session. A panel of senior experts will be present to provide active feedback to the presenters on how to improve and maximize their work thus far.
1. Oral Presentations & Expert Feedback (Stephen Rennard, MD, Gerard Turino, MD, James Kiley, PhD, Sonia Buist, MD, D. Kyle Hogarth, MD )
12:00-1:00pm
Lunch & Exhibits
1:00-2:45pm
Clinical Track: Moving COPD Phenotypes into Clinical Practice
Session Chair: Frank Sciurba, MD
The session addresses why translation of new evidence on phenotypes into clinical practice remains challenging and direct relevance of emerging phenotypes to clinical decision making is still uncertain.
1. COPD Phenotypes: Why are they clinically relevant? (Frank Sciurba, MD) 2. The Biology of Phenotypes: What we do and don’t know? (Avrum Spira, MD, MSc) 3. Emphysema With and Without Airflow Obstruction: Is it a different disease? (George Washko, MD) 4. Rapid or Slow Decliners: Different diseases or a point in time? (David Mannino, MD) 5. Phenotypes Guiding Therapy: Are we there yet? (Jerry Criner, MD)
Care Delivery Track: COPD Hospital Readmissions: Understanding the Causes, Identifying the Solutions & Measuring the Results
The threat of penalties for excess readmissions in COPD has prompted hospital systems, clinicians and community organizations to think differently about how they provide care. This session will review best practices, available research and clinical implications of the CMS penalties for excess readmissions. Discussion will identify ways the audience members can participate in a collaborative path forward.
1. What is the Problem: Statistics and Root Causes-The Same in COPD as in Other Chronic Diseases? (Byron Thomashow, MD) 2. What Solutions Exist Now-Randomized Controlled Trials? (Jerry Krishnan, MD, PhD) 3. What Solutions Exist Now-An Experience in the Tobacco Capital? (Jill Ohar, MD) 4. What Solutions Exist Now-The Pittsburgh Experience? (Keith Kanel, MD) 5. What Solutions Exist Now-Project BOOST? (Mark Williams, MD) 6. Panel Discussion-How do we Measure Results & Other Key Issues for the COPD Readmissions Summit (All Speakers)
Research Track: The Science of Exacerbations
Session Chair: Fernando Martinez, MD
Recent developments in the design and validation of tools to diagnose exacerbations and measure their severity and duration will be reviewed. Exacerbations that can have adverse effects on long term outcomes in COPD will be reviewed from the perspective of modifying outcomes in specific patients.
1. Why Worry About Exacerbations? (Steven Gay, MD, MSc) 2. What Do We Know About Exacerbations? (Sanjay Sethi, MD) 3. What Happens During an Exacerbation? (Robert Stockley, MD, DSc, FRCP) 4. How Do We Manage Exacerbations? (Fernando Martinez, MD)
2:45-3:00pm
Refreshment Break & Exhibits
3:00-5:00pm
Concluding Plenary Session: The Future of COPD in America
The breakout sessions are important parts of COPD8USA in that they allow a more intense focus on recent innovations in research, care delivery and clinical work. This final session will feature the Chairs of each track in an overview of the key findings of each of the four sessions within the tracks. The concluding discussion will look towards the future of COPD research and clinical care.
1. COPD in America-CDC Keynote Outlook (Janet Croft, PhD-via live video) 2. Chair Presentations: Research Track (Stephen Rennard, MD), Care Delivery Track (Byron Thomashow, MD), Clinical (Ravi Kalhan, MD) 2. Facilitated Concluding Discussion: A call to action around dissemination and implementation.
COPD Patient Community Education Workshop-June 14, 2013
Please contact Scott Cerreta at scerreta@copdfoundation.org for any questions relating to this session.
Register
10:00-12:00pm
Joint Session with COPD8USA followed by lunch in the exhibit hall
1:00-2:30pm
Interdisciplinary Panel Discussion-Ask the Experts
Session Chair: Peter Salgo, MD
Panelists: Dan Dilling, MD, Bob Cohen, MD, Susan Corbridge, PhD, APN, ACNP, Rachel Tappan, PT, Gail Harris, RT, Donna Serlin, RT with her patient harmonica group, Grace Anne Dorney Koppel, Patient Advocate
To jump start the discussion, this session will open with a 3D Interactive that illustrates the pathology of COPD. Patients and caregivers are rarely presented with an opportunity to meet their entire healthcare provider team, leaving them in the dark about who is coordinating their care, who can help the best with what issue and in some cases, overwhelmed with navigating the system all together. The COPD Foundation’s Community Education Workshop Series and the Respiratory Health Association’s patient conferences have brought the experts to the patients across the country to help create educated, empowered and team oriented community partnerships. COPD patient advocates from across the country attending COPD8USA will join with the Chicago area patient community for this unique facilitated panel discussion.
1. Introductions: What I do to Help Your COPD (Panelists TBD) 2. Open Ask the Expert Panel